TG Therapeutics | TGTX - Cost Of Sales

Stock Price
28.86
Daily Change
1.10 3.96%
Monthly
-4.88%
Yearly
-12.78%
Q1 Forecast
28.52

TG Therapeutics reported $28.09M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Amgen USD 1.79B 128M Dec/2025
Ardelyx USD 3.98M 10.84M Sep/2025
Bayer EUR 4.31B 57M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Corcept Therapeutics USD 4.6M 1.16M Sep/2025
Dynavax Technologies USD 14.4M 368K Sep/2025
Gilead Sciences USD 1.57B 68M Sep/2025
J&J USD 7.97B 689M Dec/2025
Novartis USD 3.54B 217M Sep/2025
PTC Therapeutics USD 23.32M 7.83M Sep/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
TG Therapeutics USD 28.09M 9.15M Sep/2025
Vertex Pharmaceuticals USD 414.8M 7.3M Sep/2025